Growing Global Aging Demand Will Expand Affordable Biosimilars
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 20 Analysts
Published
28 Jun 25
Updated
20 Aug 25
AnalystHighTarget's Fair Value
₹465.00
22.7% undervalued intrinsic discount20 Aug
₹359.50
1Y
1.8%7D
-1.3%